PB-718
- Generic Name
- PB-718
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.
- First Posted Date
- 2023-11-27
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- PegBio Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT06147544
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- PegBio Co., Ltd.
- Target Recruit Count
- 82
- Registration Number
- NCT05021666
- Locations
- 🇺🇸
Covance Clinical Research Unit Inc., Daytona Beach, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath